These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [The use of asparaginase preparations for the treatment of tumors and leukemia (review of the literature)]. Nikolaev AIa Probl Gematol Pereliv Krovi; 1969 Jul; 14(7):51-60. PubMed ID: 4903458 [No Abstract] [Full Text] [Related]
7. [Asparaginase and acute leukemia]. Benbenishti D Harefuah; 1971 Feb; 80(3):156. PubMed ID: 5099261 [No Abstract] [Full Text] [Related]
8. [Asparaginase: a new element in the treatment of acute leukemia?]. Teulings FA; Bakkeren JM Ned Tijdschr Geneeskd; 1970 Jul; 114(27):1137-40. PubMed ID: 4915105 [No Abstract] [Full Text] [Related]
9. [L-asparaginase in leukemia]. Böttiger LE Nord Med; 1967 Nov; 78(46):1521. PubMed ID: 6065209 [No Abstract] [Full Text] [Related]
10. Prediction of response to L-asparaginase therapy. Prager MD Natl Cancer Inst Monogr; 1971 Dec; 34():257-62. PubMed ID: 5140872 [No Abstract] [Full Text] [Related]
11. [Biochemical and genetic aspects of the use of L-asparaginase as an antileukemic factor]. Medvedev ZhA Usp Sovrem Biol; 1971; 71(2):208-19. PubMed ID: 4935597 [No Abstract] [Full Text] [Related]
12. [Progress in researches on anti-tumor agent L-asparaginase for treatment of leukemia]. Zhou J; Jin H; Li Y; Jiang T Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2000 Sep; 17(3):343-5. PubMed ID: 11285852 [TBL] [Abstract][Full Text] [Related]
13. [L-asparaginase, a new drug of antileukemic action]. Hernádi F Orv Hetil; 1969 Jan; 110(4):187-9. PubMed ID: 5779083 [No Abstract] [Full Text] [Related]
14. L-asparaginase--antileukemia agent. Yaqub M J Pak Med Assoc; 1975 Mar; 25(3):56-8. PubMed ID: 814292 [No Abstract] [Full Text] [Related]
17. L-Asparaginase: discovery and development as a tumor-inhibitory agent. Broome JD Cancer Treat Rep; 1981; 65 Suppl 4():111-4. PubMed ID: 7049374 [No Abstract] [Full Text] [Related]
18. Introduction to New Drug Seminar: Daunorubicin and L-asparaginase. Weiss RB; Bono VH Cancer Treat Rep; 1981; 65 Suppl 4():1-2. PubMed ID: 7049372 [No Abstract] [Full Text] [Related]
19. [Immunosuppressive effect of L-asparaginase]. Emmerling P; Finger H Dtsch Med Wochenschr; 1970 Jul; 95(30):1578-9. PubMed ID: 5431973 [No Abstract] [Full Text] [Related]
20. Eighth new drug seminar on l-asparaginase and daunorubicin. Division of Cancer Treatment. National Cancer Institute. December 17, 1979 Bethesda, Maryland. Cancer Treat Rep; 1981; 65 Suppl 4():1-130. PubMed ID: 7346157 [No Abstract] [Full Text] [Related] [Next] [New Search]